AMP was contracted by WHO/HQ/IVB to conduct the Effective Vaccine Management (EVM) assessment of Djibouti.

According to the WHO, “EVM is designed to help countries to develop strength-in-depth by building a culture of quality based on a structured approach to supply chain management, monitoring and evaluation.” The EVM tool is used to assess the quality and sufficiency of the seven component elements of an effective supply chain and these components are measured using nine basic criteria. Each criterion is divided into a number of requirements and sub-requirements; together they characterize the fundamental qualities of a good vaccine supply chain. The tool uses a structured questionnaire that is designed to allow the evaluation of four distinctly different levels in the supply chain (the primary, the sub-national, the lowest delivery, and the service points). A score of 80% is required to meet the EVM standard and spider charts are used to illustrate the scores. The assessment generates an improvement plan of the supply chain and this report, along with the EVM report, are mandatory for GAVI funding.

For the EVM assessment, AMP, as the lead coordinator, had the following objectives:


AMP’s assessment was successful. Djibouti received approval from the IRC/GAVI board for introduction of both PCV and rotavirus vaccines. Furthermore, AMP’s assessment was one of the 16 assessments that received a AA rating from GAVI. This grade implies that Djibouti’s EVM report and improvement plan were both “Fit for Purpose.”